Inactive Instrument

Highlights RLS Global AB (publ)

Equities

RLS

SE0005190725

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

RLS Global and Convatec Agree to Terminate Collaboration Agreement	Nov. 09	CI
RLS Global AB Announces First Patient Included in New Clinical Investigation on Pressure Ulcers	23-09-06	CI
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
RLS Global AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
RLS Global AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-28	CI
RLS Global AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
RLS Global AB Introduces Chlorasolv in the Veterinary Care Segment in Scandinavia	22-06-01	CI
Swedish Pharmaceutical Group RLS Global Taps Local Distributor In Middle East	22-05-30	MT
RLS Global AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
RLS Global AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
RLS Global AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-25	CI
RLS Global and ConvaTec Continues Progress with the Distribution and Commercialisation of ChloraSolv in Europe	22-01-12	CI
RLS Global AB Receives its First Order from ConvaTec	21-11-19	CI
RLS Global AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Rls Global AB Provides Livestream Strategy Update Focusing on the Global Collaboration with Conva tec Ltd	21-10-08	CI
RLS Global : Diabetic Foot Ulcer Treatment Wins New Zealand Approval	21-08-30	MT
Rls Global AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-16	CI
RLS Global AB and Convatec Ltd Sign Agreement on Global Commercial Rights for Chlorasolv	21-06-17	CI
RLS Global AB Announces Outcome of the Complete Clinical Study ChloraSolv01	21-06-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights RLS Global AB (publ)

Equities

RLS

SE0005190725

Highlights

Filters